Vigorous innate and virus-specific cytotoxic T-lymphocyte responses to murine cytomegalovirus in the submaxillary salivary gland. - Wikidata - awgldk - TriplyDB

Vigorous innate and virus-specific cytotoxic T-lymphocyte responses to murine cytomegalovirus in the submaxillary salivary gland.

Vigorous innate and virus-specific cytotoxic T-lymphocyte responses to murine cytomegalovirus in the submaxillary salivary gland.

http://www.wikidata.org/entity/Q34465970

about

Direct and Indirect Effects of Cytomegalovirus-Induced γδ T Cells after Kidney Transplantation Immunobiology of congenital cytomegalovirus infection of the central nervous system—the murine cytomegalovirus model Natural killer cells regulate murine cytomegalovirus-induced sialadenitis and salivary gland disease.Salivary gland NK cells are phenotypically and functionally unique Innate immunity defines the capacity of antiviral T cells to limit persistent infection Absence of cross-presenting cells in the salivary gland and viral immune evasion confine cytomegalovirus immune control to effector CD4 T cells.CD8+ T lymphocytes control murine cytomegalovirus replication in the central nervous system of newborn animals.Squalamine as a broad-spectrum systemic antiviral agent with therapeutic potential.UNC93B1 mediates innate inflammation and antiviral defense in the liver during acute murine cytomegalovirus infection.Recent advances in designing an effective vaccine to prevent cytomegalovirus-associated clinical diseases.Attenuation of innate immunity by cytomegalovirus IL-10 establishes a long-term deficit of adaptive antiviral immunity Current concepts: mouse models of Sjögren's syndrome.Murine cytomegalovirus interference with antigen presentation contributes to the inability of CD8 T cells to control virus in the salivary gland.CMV-independent lysis of glioblastoma by ex vivo expanded/activated Vδ1+ γδ T cells.CXCR3-dependent recruitment of antigen-specific T lymphocytes to the liver during murine cytomegalovirus infection.Cytomegalovirus-Specific IL-10-Producing CD4+ T Cells Are Governed by Type-I IFN-Induced IL-27 and Promote Virus Persistence.Cytomegalovirus exploits IL-10-mediated immune regulation in the salivary glands Shared reactivity of V{delta}2(neg) {gamma}{delta} T cells against cytomegalovirus-infected cells and tumor intestinal epithelial cells A focused salivary gland infection with attenuated MCMV: an animal model with prevention of pathology associated with systemic MCMV infection.Animal models in autoimmune diseases: lessons learned from mouse models for Sjögren's syndrome.Immunobiology of human cytomegalovirus: from bench to bedside.Innate lymphocyte and dendritic cell cross-talk: a key factor in the regulation of the immune response.Vaccination against a virus-encoded cytokine significantly restricts viral challenge CD28/B7-mediated co-stimulation is critical for early control of murine cytomegalovirus infection γδ T Cell-Mediated Immunity to Cytomegalovirus Infection.The death receptor 3/TL1A pathway is essential for efficient development of antiviral CD4⁺ and CD8⁺ T-cell immunity.Salivary gland resident APCs are Flt3L- and CCR2-independent macrophage-like cells incapable of cross-presentation.Feeling manipulated: cytomegalovirus immune manipulation.Lytic viral replication and immunopathology in a cytomegalovirus-induced mouse model of secondary hemophagocytic lymphohistiocytosis.CD103+ CD11b- salivary gland dendritic cells have antigen cross-presenting capacity.

P2860

Q26863724-8967E80F-CBB0-4AF7-B571-2052D5BF4664 Q27026924-9F859EDC-0F1B-4641-B343-F084C731BFF6 Q30425772-D98E993D-7D3D-4D6E-B605-D6ACBDC3EAD7 Q33797827-A64126B2-CB6E-47F0-9F29-316D4452C609 Q33902354-78588780-4719-4DB7-A8F3-7788717DFA80 Q34013634-E9FA28CB-3DEF-42E6-A706-E70D94578686 Q34166586-934951CD-C939-492F-893D-A5202BFCECE5 Q34217620-58D7849E-D839-4374-A930-0CC9C621B980 Q34314248-CB58E909-86F8-45EF-80D9-335F1B704AAA Q34349745-AA35627F-B27B-42FE-9338-C3F38AAE9DF5 Q34450223-10768F5D-7B91-4BE0-8D31-F833B639A4B8 Q34479267-702256DF-EB61-4790-B5A8-B67573EF4AF6 Q34546047-1F123DC4-43CE-42B6-9BD2-2EAE6F970274 Q34946005-714F29C2-1C76-472E-846D-440CEDD1FA57 Q35635259-4446D9B4-747D-47EE-B014-E222917C02C9 Q36214992-9CFFACB6-B975-46C3-A69F-0DB97FB5466C Q36229323-C850D532-E694-4FDC-B395-CD4DAF82EE69 Q36403003-0058B4D1-9068-40D6-8A68-29C0C2CF475B Q36422913-F173F8B8-803D-44EF-AD5D-9883B2133561 Q37016308-DA23C208-2719-4733-9226-1E30878130F7 Q37050965-8D9D2AF2-49CB-4462-B49E-E6EA76E68480 Q37108806-4790A5D6-E40C-4FEB-A718-34B6D70A8A5B Q37252720-142C1760-B588-4693-94E7-E79670F8A5FF Q37341040-DE4DA7C8-675A-41E7-95DD-41A5F060BC6E Q37632938-27E28F56-E7FE-4C22-9027-343ADD15F42B Q41835480-19C136CB-B8F4-4303-97FB-ADC92A6112EA Q42253353-F307E3D6-8BF1-419C-A7BD-9EEA19ED5A11 Q43085159-D4FC743E-2400-436A-A511-2F64969C871E Q47192748-B41C6582-FC5B-4D3A-A347-D803398E9A60 Q51319086-A88D473C-F5E2-454C-9F96-292EB9640781

P2860

Vigorous innate and virus-specific cytotoxic T-lymphocyte responses to murine cytomegalovirus in the submaxillary salivary gland.

http://www.wikidata.org/entity/Q34465970

description

2003 nî lūn-bûn

@nan

2003 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2003 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2003年の論文

@ja

2003年論文

@yue

2003年論文

@zh-hant

2003年論文

@zh-hk

2003年論文

@zh-mo

2003年論文

@zh-tw

2003年论文

@wuu

name

Vigorous innate and virus-spec ...... e submaxillary salivary gland.

@ast

Vigorous innate and virus-spec ...... e submaxillary salivary gland.

@en

Vigorous innate and virus-spec ...... e submaxillary salivary gland.

@nl

type

label

Vigorous innate and virus-spec ...... e submaxillary salivary gland.

@ast

Vigorous innate and virus-spec ...... e submaxillary salivary gland.

@en

Vigorous innate and virus-spec ...... e submaxillary salivary gland.

@nl

prefLabel

Vigorous innate and virus-spec ...... e submaxillary salivary gland.

@ast

Vigorous innate and virus-spec ...... e submaxillary salivary gland.

@en

Vigorous innate and virus-spec ...... e submaxillary salivary gland.

@nl

P1433

Q34465970-33BA550F-3EB9-4F75-956A-119AA37F8B56

P1476

Q34465970-FC0E4360-19E7-42D4-9E5E-E2AADCF8D5BC

P2093

Q34465970-37CF69C7-27D4-4D43-ACDE-5B87FDF7D759

Q34465970-6880F28E-E67B-40B3-99AA-ED33A799C5AA

Q34465970-8FABD9B6-3616-419E-8660-B2B7E5E37D18

Q34465970-CB30993B-4631-4E0A-B913-80D14012B862

Q34465970-FD6BFCCF-18FF-4F58-A86B-22C7686BD361

P2860

Q34465970-056877BB-465E-42CE-8DB8-B0DE89EF8D5D

Q34465970-0AFABBE3-29FA-47D3-88FD-AC4E92AD1BD4

Q34465970-0E2F808C-DEF7-4B45-BC01-2CB336986B06

Q34465970-0EEB204F-5926-4CB2-814E-3AFB397060D7

Q34465970-16A8EF44-7B15-4313-9C6E-41A24BBFA471

Q34465970-1875C4F5-0473-4C18-9509-A10E921FCC6C

Q34465970-298CEA0C-A9C3-444B-AFC6-09318FB2EC49

Q34465970-29A27632-AAEA-4E30-80C2-264535FEAAA6

Q34465970-2BCBA208-E9B3-4AF0-96E0-93DB3CF77604

Q34465970-2BD6930F-9D71-4A49-A25E-E3CECCA62A3B

P304

Q34465970-BE62CC5F-D0A8-4980-AF31-82EBE65940E0

P31

Q34465970-69FB57B2-32D4-45F1-B0B5-1E265449EA0B

P356

Q34465970-CD8F0193-36F0-4228-81D2-B65A4E314EF5

P407

Q34465970-9C3E6E19-CD72-41E6-9DA7-E484C8064D76

P433

Q34465970-0206769F-E56E-4713-BDFE-D0143D8AE6E2

P478

Q34465970-A6A7EE6A-220F-4DA6-B678-EC0138284E42

P577

Q34465970-970ADFDA-9D83-4684-ACFC-EBDAE3CF5DAD

P698

Q34465970-6F06D745-3792-4AE4-9258-923B06BB0D40

P921

Q34465970-0D6B52DB-2150-4439-8AD4-9AC1CB3623BA

Q34465970-110DFD6A-4745-4C75-8F88-61ED5AE27429

P932

Q34465970-8E7EA944-0F88-498C-9DAB-7875F19BA390

P356

JVI.77.3.1703-1717.2003

P1433

Journal of Virology

P1476

Vigorous innate and virus-spec ...... e submaxillary salivary gland.

@en

P2093

Ann E Campbell

http://www.w3.org/2001/XMLSchema#string

Jacquelyn S Slater

http://www.w3.org/2001/XMLSchema#string

Mark P Birkenbach

http://www.w3.org/2001/XMLSchema#string

Victoria J Cavanaugh

http://www.w3.org/2001/XMLSchema#string

Yuping Deng

http://www.w3.org/2001/XMLSchema#string

P2860

Identification of a novel chemokine (CCL28), which binds CCR10 (GPR2)

A novel chemokine ligand for CCR10 and CCR3 expressed by epithelial cells in mucosal tissues

CD8+ cytotoxic lymphocyte responses against cytomegalovirus after liver transplantation: correlation with time from transplant to receipt of tacrolimus.

Natural killer cells in antiviral defense: function and regulation by innate cytokines.

Mucosal and parenteral vaccination against acute and latent murine cytomegalovirus (MCMV) infection by using an attenuated MCMV mutant.

Control of murine cytomegalovirus in the lungs: relative but not absolute immunodominance of the immediate-early 1 nonapeptide during the antiviral cytolytic T-lymphocyte response in pulmonary infiltrates

Enrichment of immediate-early 1 (m123/pp89) peptide-specific CD8 T cells in a pulmonary CD62L(lo) memory-effector cell pool during latent murine cytomegalovirus infection of the lungs

Experimental preemptive immunotherapy of murine cytomegalovirus disease with CD8 T-cell lines specific for ppM83 and pM84, the two homologs of human cytomegalovirus tegument protein ppUL83 (pp65).

Murine cytomegalovirus CC chemokine homolog MCK-2 (m131-129) is a determinant of dissemination that increases inflammation at initial sites of infection.

Gamma interferon-dependent clearance of cytomegalovirus infection in salivary glands

P304

1703-1717

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/JVI.77.3.1703-1717.2003

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

77

http://www.w3.org/2001/XMLSchema#string

P577

2003-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

12525604

http://www.w3.org/2001/XMLSchema#string

P921

Cytomegalovirus

P932

140858

http://www.w3.org/2001/XMLSchema#string